Indivior Pharmaceuticals (INDV) Net Cash Flow (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Net Cash Flow of -$21.0 million for Q1 2026, down 139.62% year-over-year from $53.0 million in Q1 2025, and up 91.6% quarter-over-quarter from -$250.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Net Cash Flow (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Net Cash Flow history runs 3 years deep, the most recent figure standing at -$21.0 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 139.62% year-over-year to -$21.0 million; the TTM figure through Mar 2026 stood at -$197.0 million (down 258.87% YoY), while the FY2025 annual figure was -$123.0 million, down 4200.0% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$21.0 million, up from -$250.0 million in the prior quarter.
- The five-year high for Net Cash Flow was $136.0 million in Q2 2025, with the low at -$250.0 million in Q4 2025.
- The 3-year median for Net Cash Flow is -$14.0 million (2024), against an average of -$15.7 million.
- Peak annual rise in Net Cash Flow reached 177.94% in 2025, while the deepest fall reached 906.45% in 2025.
- Indivior Pharmaceuticals' Net Cash Flow stood at $31.0 million in 2024, then sank by 906.45% to -$250.0 million in 2025, then jumped by 91.6% to -$21.0 million in 2026.
- Business Quant data shows INDV's Net Cash Flow at -$21.0 million in Q1 2026, -$250.0 million in Q4 2025, and -$62.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.51 Bn | 4.29 Bn | 294.00 Mn | 48.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.00 Mn |
| Jun 30, 2026 | 48.00 Mn |
| Mar 31, 2026 | -21.00 Mn |
| Mar 31, 2026 | -21.00 Mn |
| Dec 31, 2025 | -250.00 Mn |
| Dec 31, 2025 | -250.00 Mn |
| Sep 30, 2025 | -62.00 Mn |
| Sep 30, 2025 | -62.00 Mn |
| Jun 30, 2025 | 136.00 Mn |
| Jun 30, 2025 | 136.00 Mn |
| Mar 31, 2025 | 53.00 Mn |
| Mar 31, 2025 | 53.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Sep 30, 2024 | -14.00 Mn |
| Sep 30, 2024 | -14.00 Mn |
| Jun 30, 2024 | 54.00 Mn |
| Jun 30, 2024 | 54.00 Mn |
| Mar 31, 2024 | -68.00 Mn |
| Mar 31, 2024 | -68.00 Mn |